 Home > Active Ingredient News > Antitumor Therapy > Nat Commun: The immune evolution process from pre-tumor formation to invasive lung adenocarcinoma and its potential molecular characteristics

Nat Commun: The immune evolution process from pre-tumor formation to invasive lung adenocarcinoma and its potential molecular characteristics

 Last Update: 2021-06-01
 Source: Internet
 Author: User

Tags

tumor cartoon

th1 immune response

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Although encouraging progress has been made in clinical treatment, lung cancer is still one of the leading causes of cancer-related deaths worldwide, mainly caused by incurable late diagnosis .

diagnosis

Computer tomography (CT) -guided lung cancer screening has reduced the mortality rate of lung cancer by 26-61%, which emphasizes the necessity of early detection and intervention of the disease to reduce the incidence and mortality of lung cancer.

Screening and prevention An in-depth understanding of the relevant molecular mechanisms of early lung cancer can speed up the precise diagnosis of the disease and the development of effective prevention and treatment strategies.

At present, about the anti-cancer immune -related effects of early molecular mechanisms of carcinogenesis force ADC is unclear.

immunity

IPN immune landscape at different stages and its related genomic and epigenome characteristics

The results show that in the continuous process from the formation of lung cancer to pre-invasive lesion ADC, minimally invasive ADC, and invasive ADC, the immune response of anti-cancer immunity gradually decreases, and the intensity of this regulation gradually increases, including the down-regulation of immune activation signals and immune response.

The immune landscape from preneoplastic lesions to aggressive lung adenocarcinoma

All in all, the results of the study show that treatments targeting the immune microenvironment of patients with lung cancer precursors can prevent the development of aggressive lung cancer.

Treating the immune microenvironment of patients with lung cancer precursors can prevent the development of aggressive lung cancer.

org/10.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.